EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,130
+310 (2.24%)
Sep 19, 2025, 3:30 PM KST

EuBiologics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
517,500443,892418,137324,3591,271,414655,399
Market Cap Growth
69.16%6.16%28.91%-74.49%93.99%-
Enterprise Value
-440,624418,132320,5501,239,111-
Last Close Price
14130.0012150.0011470.008900.0035050.0021300.00
PE Ratio
20.8117.85----
PS Ratio
5.394.626.035.8532.2823.01
PB Ratio
--3.992.7210.846.77
P/TBV Ratio
--3.882.6610.756.87
P/FCF Ratio
--21.43---
P/OCF Ratio
--15.8150.37-395.02
EV/Sales Ratio
-4.596.035.7831.46-
EV/EBITDA Ratio
--24.7977.93--
EV/EBIT Ratio
-12.8454.31---
EV/FCF Ratio
--21.43---
Debt / Equity Ratio
--0.140.130.130.23
Debt / EBITDA Ratio
--0.883.81--
Debt / FCF Ratio
--0.76---
Asset Turnover
--0.440.360.26-
Inventory Turnover
--2.261.952.01-
Quick Ratio
--0.780.591.991.65
Current Ratio
--1.631.673.112.03
Return on Equity (ROE)
---13.70%-2.90%-26.17%-
Return on Assets (ROA)
--3.07%-1.51%-2.95%-
Return on Capital (ROIC)
--3.78%-1.76%-3.58%-
Return on Capital Employed (ROCE)
--6.10%---
Earnings Yield
4.81%5.60%-3.32%-0.34%-2.17%-9.18%
FCF Yield
--4.67%-0.81%-1.12%-0.97%
Buyback Yield / Dilution
---0.13%-2.68%-26.53%-
Updated Mar 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.